Teva Pharmaceutical Industries (TEVA) Enterprise Value: 58.81B

Teva Pharmaceutical Industries Ltd. (TEVA)

39.10 -0.03 (-0.08%) USD | NYSE | Oct 07, 09:35

Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 1998. Start Trial.

Date	Value
October 06, 2026	58.81B
October 05, 2026	59.43B
October 02, 2026	59.28B
October 01, 2026	59.02B
September 30, 2026	59.36B
September 29, 2026	59.60B
September 28, 2026	58.52B
September 25, 2026	58.88B
September 24, 2026	60.08B
September 23, 2026	58.67B
September 22, 2026	59.26B
September 21, 2026	59.89B
September 18, 2026	58.63B
September 17, 2026	58.88B
September 16, 2026	58.11B
September 15, 2026	58.95B
September 14, 2026	58.33B
September 11, 2026	56.33B
September 10, 2026	55.57B
September 09, 2026	56.15B
September 08, 2026	56.05B
September 04, 2026	55.58B
September 03, 2026	55.89B
September 02, 2026	56.90B
September 01, 2026	55.38B

Date	Value
August 31, 2026	55.22B
August 28, 2026	55.68B
August 27, 2026	57.05B
August 26, 2026	57.40B
August 25, 2026	57.61B
August 24, 2026	56.25B
August 21, 2026	56.72B
August 20, 2026	56.11B
August 19, 2026	56.88B
August 18, 2026	55.84B
August 17, 2026	55.70B
August 14, 2026	56.06B
August 13, 2026	55.77B
August 12, 2026	56.03B
August 11, 2026	55.72B
August 10, 2026	55.33B
August 07, 2026	54.42B
August 06, 2026	53.78B
August 05, 2026	53.67B
August 04, 2026	53.33B
August 03, 2026	53.37B
July 31, 2026	54.01B
July 30, 2026	54.48B
July 29, 2026	53.66B
July 28, 2026	50.12B

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks